-
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT07227532 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years and older ·
Sex: All (male and female)
· Virginia: Winchester
-
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Virginia: Falls Church, Norfolk, Richmond
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Charlottesville, Falls Church
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Charlottesville, Falls Church, Richmond
-
CardioFocus HeartLight Post-Approval Study
NCT03168659 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Charlottesville
-
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
NCT07298473 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Falls Church, Lynchburg, Newport News
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
NCT06212791 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Richmond
-
Endocardial Mapping With the CoreMap EP Mapping System
NCT06529978 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Virginia: Richmond
-
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
NCT07308847 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Virginia: Falls Church, Norfolk
-
Medtronic Terminate AF Study
NCT03546374 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Norfolk
-
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NCT06445439 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 90 Years ·
Sex: All (male and female)
· Virginia: Fairfax
-
PULSED AF Post-Approval Study
NCT06578104 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Charlottesville
-
REPRESENT-PF Registry
NCT07535268 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Winchester
-
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Lynchburg, Midlothian, Richmond, Winchester
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Norfolk
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Manassas, Vienna
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
NCT07430956 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Vienna
-
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200 ·
Phase: Phase 3 ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Virginia: Falls Church, Fredericksburg, Manassas, Roanoke
-
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Charlottesville
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
NCT06324201 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Virginia: Lynchburg, Richmond, Winchester
-
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987 ·
Phase: Phase 3 ·
Ages: 22 Years to 85 Years ·
Sex: All (male and female)
· Virginia: Charlottesville, Richmond